12,20-Dioxo-5α-pregnan-3β-yl acetate, obtained from hecogenin, was treated with NaH in DMSO to yield the bridged cyclopropano ketone, 3β-hydroxy-12α,21-cyclo-12β,21-methano-5α,17α-pregnan-20-one. In tert-BuOH the reaction leads to 3β-hydroxy-12,21-cyclo-5α-pregn-12,21-en-20-one. Experimental data prove that the new methylene group of the cyclopropane ring came from DMSO.
Recently, we have been involved in the synthesis of novel neurosteroids [1] [2] [3] [4] and their effects on the function of the GABA A receptor. Several research laboratories have produced and tested hundreds of analogs of 3α-hydroxy-5α-pregnan-20-one (1, "allopregnanolone") in search of new types of anesthetics, analgesics and tranquilizers. From this group of compounds a subset of B-ring modified analogs was analyzed using methods of molecular modeling and a few hypotheses were formulated to rationalize the structure-activity relationship. We endeavored to do the same with C-ring modifications of neurosteroid 1 (Figure 1) . One of the compounds, designed to usefully widen the available selection, was a 12-exomethylene derivative of allopregnanolone (2) , which should have been accessible by application of the Wittig reaction to the known 12-oxo derivative of allopregnanolone, compound 3.
Surprisingly, the treatment of 12,20-dioxo-5αpregnan-3β-yl acetate (4) with triphenylmethylphosphonium iodide and sodium hydride in dimethylsulfoxide yielded a new compound (5, 51%) with the expected number of carbon and oxygen atoms, but lacking two hydrogen atoms (see MS in the Experimental: C 22 H 32 O 2 ). The same compound (5) was obtained even in the absence of a Wittig reagent. The 1 H NMR spectrum of compound 5 lacked the olefin proton signals expected for compound 2 and a three-proton singlet typical of 20-oxopregnanes. The IR spectrum (ν C=O at 1710 cm -1 ) showed one oxo group and suggested the presence of a cyclopropane ring. Its 13 C NMR spectrum revealed 22 13 C signals, which indicated the presence of an extra non-olefinic carbon atom. A combination of APT and H,C-HMBC (cross peaks between H-18 at δ 0.94 and C-12 at δ 21.16) resulted in a structure containing a quaternary C-12 and an additional CH 2 group connecting C-12 and C-21. Apparently, enolization of carbonyl groups at C-11 and C-17 took place during an initial step, which made the C-17 configuration uncertain ( Figure 2 ).
An intermediate of the process, compound 6, was produced in tert-butanol under similar conditions and was then converted into compound 5 by reaction with dimsyl sodium. The configuration at C-17 of compound 5 was based on analysis of a ROESY spectrum of the intermediate 6: NOE cross-peaks between H-18 (δ 1.08) and H-17β (δ 2.30) prove the 17α configuration of the side chain. Analogously, the configuration of the 22-methylene group was determined by a ROESY spectrum of product 5 indicating the spatial proximity of H-22 (δ 1.30) and H-17β (δ 1.96).
Another experiment supplemented the proof: when the reaction was carried out in deuteriated DMSO-d 6 , a polydeuterated compound 5 was isolated. Due to alkali-induced enolization before the reaction, additional deuterium atoms were placed in positions 11, 17, and 21. The 13 C NMR spectrum of the labeled derivative 5 required more attention since direct observation of 13 C signals did not provide direct information about all carbons in the structure (namely, signals of C-11, C-12, C-13, C-17 and C-22 were not observed). They, however, could be extracted from a H, C-HMBC spectrum. The 1 H NMR spectrum lacked signals for H-22, but also of enolizable protons in positions 11, 17, and 21, which in turn gives information about the deuterium positions.
Should the above Michael addition of dimsyl sodium to a conjugated ketone 6 be a more general reaction, it could have been suitable for the preparation of many useful compounds. Unfortunately, dimsyl sodium failed to add to testosterone (8) and 3β-hydroxy-5α-androst-15-en-17-one (9) under the given conditions. For biological experiments we converted the 3β-hydroxy derivative 5 into its tosylate 10 ( Figure 4) , which was solvolyzed with KNO 2 in DMSO, yielding a corresponding 3α-analog (11). Its biological activity will be reported elsewhere. Hydroxy-12α,21-cyclo-12β,21-methano-5α pregnan-20-one (5): NaH-paraffin (110 mg) in dimethylsulfoxide (4 mL) was stirred at 75 o C for 1 h under argon. The solution turned light green. After cooling to room temperature, a solution of compound 4 (257 mg; 0.69 mmol) in DMSO (4 mL) was added. After stirring at 80 o C for 6 h, the reaction was cooled to room temperature and quenched with ice. The organics were extracted into ethyl acetate and dried over sodium sulfate. Rapid silica column filtration (light petroleum) was performed. The column was then eluted with ethyl acetate and yielded 115 mg (51%) of compound 5. Preparation of cyclomethanopregnanone from dioxopregnanyl acetateNatural Product Communications Vol. 2 (11) 2007 1093 J 2β,1α = 12.9, J 2β,3α = 11.0, J 2β,1α = 4.1, H-2β), 1.55 (1H, qd, J 8β,7α = 11.8, J 8β,14α = J 8β,9α = 10.7, J 8β,7β = 4.1, H-8β), 1.58 (2H, m, H-1β and H-4α 96 (1H, m, H-17β ), 1.70 (1H, dd, J gem = 14.5, J 11β,9α = 12.5, H-11β), 3.59 (1H, tt, J 3α,2 = 11.0, 4.8, J 3α,4 = 11.0, 4.8, H-3α) . 13 
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Deuterium-labeled compound 5:
When the reaction was carried out in DMSO-d 6 , the labeled product 5 had the following spectral characteristics. 1.55 (1H, qd, J 8β,7α = 11.7, J 8β,14α = 11.1, J 8β,9α = 10.6, J 8β,7β = 4.0, H-8β), 1.58 (2H, m, H-1β and H-4α), 1.65 (1H, m, H-15α), 1.70 (1H, m, H-7β), 1.74-1.86 (3H, m, H-2α and H-16), 3.59 (1H, tt, J 3α,2 = 11.0, 4.8, J 3α,4 = 11.0, 4.8, H-3α) . 13 Hydroxy-12,21-cyclo-5α-pregn-12,21-en-20-one  (6) : Potassium tert-butoxide (98 mg, 0.87 mmol) was refluxed for 15 min in 8 mL of tert-butanol. Compound 4 (58 mg, 0.16 mmol) in tert-butanol (2 mL) was added dropwise. The reaction was followed by TLC (benzene-ether, 4:1) and was quenched after 5h. The tert-butyl alcohol was removed by evaporation and the residue was acidified with 5% HCl. The product was extracted in chloroform and yielded 48 mg (98%) of compound 6. Hydroxy-12α,21-cyclo-12β,21-methano-5αpregnan-20-one (11) : To a solution of tosylate 10 (28 mg, 0.06 mmol) in N,N-dimethylformamide (3 mL), potassium nitrite (100 mg, 1.45 mmol) was added. The reaction mixture was stirred at 110 o C for 4 h and then quenched with water. Organics were extracted into chloroform, washed with sodium hydrogen carbonate and dried over sodium sulfate. The yellow syrup was purified using preparative thin layer chromatography to yield compound 11 (6 mg, 31% 2 : C, 80.44; H, 9.82; found: C, 80.65; H, 9.72. 
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